Agreement Between the Harmonized and the Self‐Explanatory Versions of the Revised ALS Functional Rating Scale in a Clinical Setting

Documenti analoghi

• Clinical and patient‐reported outcomes and neurofilament response during tofersen treatment in SOD1‐related ALS—A multicenter observational study over 18 months
  di: Thomas Meyer, et al.
  Pubblicazione: (2024)
• Serum Cardiac Troponin T Levels as a Therapy Response Marker in Tofersen‐Treated ALS
  di: Sarah Bernsen, et al.
  Pubblicazione: (2025)
• Homecare amyotrophic lateral sclerosis (ALS): A multidisciplinary, home‐based model of care for patients with ALS and their caregivers
  di: Sarah Kristina Bublitz, et al.
  Pubblicazione: (2024)
• Embedding Palliative Care Clinicians in ALS Teams Improves ALS Clinicians' Confidence in Their Patient Management and Satisfaction With Palliative Care
  di: Astrid Grouls, et al.
  Pubblicazione: (2026)
• Are Cannabis and/or Cannabinoids a Potential Therapy for ALS ?
  di: Kent E. Vrana
  Pubblicazione: (2026)